Dietary Supplement
Nepro
Nepro is a dietary supplement with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
withdrawn133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
Protein Supplementation in Thiazide-induced Hyponatremia
NCT02614807
completednot_applicable
Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis
NCT02371018
completedphase_3
Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
NCT00561093
Clinical Trials (3)
Showing 3 of 3 trials
NCT02614807Not Applicable
Protein Supplementation in Thiazide-induced Hyponatremia
NCT02371018Not Applicable
Acute Effects of Nutrition Supplementation on Treatment Efficiency and Hemodynamics During Dialysis
NCT00561093Phase 3
Anit-Inflammatory and Anti-Oxidative Nutrition in Dialysis Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 3